Better regenerative output after cellular input: healing hearts by combining basic fibroblast factor and cell-based therapy.
Dimmeler
Stefanie
S
Institute of Cardiovascular Regeneration, Centre for Molecular Medicine, University of Frankfurt, Frankfurt, Germany. Electronic address: Dimmeler@em.uni-frankfurt.de.
Tjwa
Marc
M
Leibniz AG, Centre for Molecular Medicine, University of Frankfurt, Frankfurt, Germany; Vesalius Research Center, Flemish Institute of Biotechnology, University of Leuven, Leuven, Belgium.
D000818:Animals; D017690:Cell Transplantation / Q000379:methods*; D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D004195:Disease Models, Animal; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D006321:Heart / Q000502:physiology; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D017202:Myocardial Ischemia / Q000473:pathology; D009389:Neovascularization, Pathologic; D013552:Swine
D016222:Fibroblast Growth Factor 2